This brand name is authorized in Nigeria.
The drug FEXOTOP contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
826Y60901U - BETAMETHASONE DIPROPIONATE
|
|
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
2
|
UNII
8X7386QRLV - GENTAMICIN SULFATE
|
|
Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits. |
|
3
|
UNII
06KB629TKV - TOLNAFTATE
|
4
|
UNII
7BHQ856EJ5 - CLIOQUINOL
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-100705 | Cream | FEXOTOP CREAM 30G CREAM 0.643mg; 1mg; 10mg; 10mg 30G | 21 NF-PP-320209 FEXOTOP CREAM 30G Clobetasol Propionate, Neomycin Sulphate, Miconazole Nitrate, Zinc Oxide & Borax Betamethasone Dipropionate, Gentamycin, Tolnaftate & Iodochlorhydroxyquin A4-100705 Drugs Imported Products 30g Prescription Only Medicine (POM) 3/8/2023 Fexona Pharmaceutical Co Ltd, 19, Akinlawon Street, Ijesha-Surulere, Lagos State. 8032587764 fexonapharmltd@yahoo.com ZEE LABORATORIES LIMITED , BEHIND 47 INDUSTRIAL AREA, PAONTA SAHIB DISTT, SIRMOUR, HIMACHAI PRADESH INDIA, India | 31/01/2024 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-100705 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.